Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adaptive dose finding based on t-statistic for dose-response trials.

Anastasia Ivanova1, James A Bolognese, Inna Perevozskaya

  • 1Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7420, U.S.A. aivanova@bios.unc.edu

Statistics in Medicine
|February 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Competing-triggering effect models for multitype recurrent event data.

Biometrics·2026
Same author

Dynamic borrowing methods for basket trials with order restrictions.

Journal of biopharmaceutical statistics·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same author

Design characteristics of sequential multiple assignment randomised trials (SMARTs) for human health: a scoping review of studies between 2009 and 2024.

BMJ open·2025
Same author

Prediction of transition probabilities in multi-state models with nested case-control data.

Biometrics·2025
Same author

Dynamic prediction by landmarking with data from cohort subsampling designs.

Statistical methods in medical research·2025
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
See all related articles

This study introduces an adaptive design for dose-response trials, improving treatment effectiveness detection and dose selection. The adaptive approach offers higher power and better dose selection compared to traditional randomized designs.

Area of Science:

  • Clinical Trials
  • Pharmacology
  • Biostatistics

Background:

  • Phase II dose-response studies aim to confirm treatment efficacy and determine optimal dosage for development.
  • Traditional randomized designs with equal allocation are standard but may not be maximally efficient.
  • Adaptive designs offer potential advantages, especially when treatment responses are observed quickly.

Purpose of the Study:

  • To propose and evaluate an adaptive design for phase II dose-response studies.
  • To enhance the efficiency of dose selection and efficacy assessment.
  • To improve the statistical power of detecting dose-response relationships.

Main Methods:

  • The proposed adaptive design concentrates patient allocation towards areas of interest (e.g., minimum clinically important effect).

Related Experiment Videos

  • It allows for early trial termination if necessary.
  • Comparison is made against traditional randomized designs with equal allocation.

    • Main Results:

    • The adaptive design demonstrated higher statistical power for detecting dose-response relationships.
    • It showed increased power when comparing treatment effects against a placebo.
    • The adaptive design selected the correct dose for further development more frequently than equal allocation designs.

    Conclusions:

    • Adaptive designs represent a more efficient approach for phase II dose-response studies.
    • This design enhances the ability to identify effective treatments and optimal doses.
    • The proposed adaptive strategy offers significant advantages over conventional randomized designs.